S
Stefan Mönig
Researcher at Geneva College
Publications - 71
Citations - 3108
Stefan Mönig is an academic researcher from Geneva College. The author has contributed to research in topics: Cancer & Esophageal cancer. The author has an hindex of 24, co-authored 71 publications receiving 2445 citations. Previous affiliations of Stefan Mönig include University of Geneva.
Papers
More filters
Journal ArticleDOI
Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial.
Salah-Eddin Al-Batran,Ralf Hofheinz,Claudia Pauligk,Hans-Georg Kopp,Georg Martin Haag,Kim Barbara Luley,Johannes Meiler,Nils Homann,Sylvie Lorenzen,Harald Schmalenberg,Stephan Probst,Michael Koenigsmann,Matthias Egger,Nicole Prasnikar,Karel Caca,Jörg Trojan,Uwe M. Martens,Andreas Block,Wolfgang Fischbach,Rolf Mahlberg,Michael R. Clemens,Gerald Illerhaus,Katja Zirlik,Dirk Behringer,Wolff Schmiegel,Michael Pohl,Michael Heike,Ulrich Ronellenfitsch,Martin Schuler,Wolf O. Bechstein,Alfred Königsrainer,Timo Gaiser,Peter Schirmacher,Wael Hozaeel,Alexander Reichart,Thorsten Oliver Goetze,Mark Sievert,Elke Jäger,Stefan Mönig,Andrea Tannapfel +39 more
TL;DR: Findings from the phase 2 part of the FLOT4 trial, which compared histopathological regression in patients treated with a docetaxel-based triplet chemotherapy versus an anthracycline-based doublet chemotherapy before surgical resection, suggest FLOT was associated with significantly higher proportions of patients achieving pathological complete regression than was ECF/ECX.
Journal ArticleDOI
[German S3-Guideline "Diagnosis and Treatment of Esophagogastric Cancer"]
Markus Moehler,Se-E. Al-Batran,T. Andus,M. Anthuber,Jann Arends,Dirk Arnold,Daniela Aust,P. Baier,Gustavo B. Baretton,J. Bernhardt,H. Boeing,E. Böhle,Carsten Bokemeyer,Jan Bornschein,W. Budach,E. Burmester,K. Caca,Wa A. Diemer,Cf F. Dietrich,MP Ebert,A. Eickhoff,C. Ell,J. Fahlke,H. Feußner,Rainer Fietkau,Wolfgang Fischbach,W. Fleig,Michael Flentje,He E. Gabbert,Pr R. Galle,M. Geissler,Ines Gockel,U. Graeven,Lars Grenacher,S. Groß,Jt T. Hartmann,M. Heike,Volker Heinemann,B. Herbst,Thomas Herrmann,S. Höcht,Rd D. Hofheinz,Heinz Höfler,T. Höhler,Ah H. Hölscher,Markus Horneber,J. Hübner,J. R. Izbicki,R. Jakobs,Christian Jenssen,Stephan Kanzler,M. Keller,Ralf Kiesslich,G. Klautke,J. Körber,Bj J. Krause,C. Kuhn,Frank Kullmann,H. Lang,Hartmut Link,Florian Lordick,K. Ludwig,Manfred P. Lutz,R. Mahlberg,Peter Malfertheiner,S. Merkel,Helmut Messmann,Hj-J. Meyer,Stefan Mönig,P. Piso,Steffen Pistorius,R. Porschen,T. Rabenstein,P. Reichardt,K. Ridwelski,Christoph Röcken,I. Roetzer,P. Rohr,W. Schepp,Pm M. Schlag,RM Schmid,Heinz Schmidberger,Wh-H. Schmiegel,Hj-J. Schmoll,G. Schuch,Christoph Schuhmacher,Kerstin Schütte,W. Schwenk,Michael Selgrad,A. Sendler,J. Seraphin,T. Seufferlein,Michael Stahl,Hubert J. Stein,C. Stoll,Martin Stuschke,Andrea Tannapfel,R. Tholen,Peter C. Thuss-Patience,K. Treml,U. Vanhoefer,M Vieth,H. Vogelsang,D. Wagner,U. Wedding,A. Weimann,H. Wilke,Ch. Wittekind +107 more
TL;DR: Authors M. Moehler, S-E.
Journal ArticleDOI
Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer: The AIO-FLOT3 Trial
Salah-Eddin Al-Batran,Nils Homann,Claudia Pauligk,Gerald Illerhaus,Uwe M. Martens,Jan Stoehlmacher,Harald Schmalenberg,Kim Barbara Luley,Nicole Prasnikar,Matthias Egger,Stephan Probst,Helmut Messmann,Markus Moehler,Wolfgang Fischbach,Jörg T. Hartmann,Frank Mayer,Heinz-Gert Höffkes,Michael Koenigsmann,Dirk Arnold,Thomas Kraus,Kersten Grimm,Stefan Berkhoff,Stefan Post,Elke Jäger,Wolf O. Bechstein,Ulrich Ronellenfitsch,Stefan Mönig,Ralf Hofheinz +27 more
TL;DR: Patients with limited metastatic disease who received neoadjuvant chemotherapy and proceeded to surgery showed a favorable survival, and the AIO-FLOT3 trial provides a rationale for further randomized clinical trials.
Journal ArticleDOI
MUC1 and Nuclear β-Catenin Are Coexpressed at the Invasion Front of Colorectal Carcinomas and Are Both Correlated with Tumor Prognosis
Stephan Baldus,Stefan Mönig,Sandra Huxel,Stephanie Landsberg,Franz-Georg Hanisch,Katja Engelmann,Paul M. Schneider,Jürgen Thiele,Arnulf H. Hölscher,Hans Peter Dienes +9 more
TL;DR: The results suggest that MUC1 and β-catenin are coexpressed at the invasion front of colorectal carcinomas and that this feature is associated with an accelerated course of disease and worse prognosis.
Journal ArticleDOI
Early gastric cancer: lymph node metastasis starts with deep mucosal infiltration.
Arnulf H. Hölscher,Uta Drebber,Stefan Mönig,C. Schulte,Daniel Vallböhmer,Elfriede Bollschweiler +5 more
TL;DR: Endoscopic mucosectomy in m3 carcinoma is questionable and in all submucosal carcinomas and lesions ≥2 cm it is not indicated, and the size of tumor showed independent influence on the rate of lymph node metastasis.